Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Please Wait
Applying Filters...
01 25Evonik
02 1Boai NKY Pharmaceuticals Ltd
03 9Gangwal Healthcare
04 13Actylis
05 4Aeon Procare
06 4Alcedo Pharmachem
07 35BASF
08 20Corel Pharma Chem
09 4Finar
10 3Gangwal Chemicals
11 1Huzhou Sunflower Pharmaceutical
12 7Ideal Cures Pvt Ltd
13 19Kerry
14 1Kima Chemical
15 1Lonza Capsugel
16 4Lubrizol Life Science Health
17 5Nomisma Healthcare
18 1Sigachi Industries
19 4The Dow Chemical Company
20 14Vertellus
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Application : Controlled & Modified Release
Excipient Details : EUDRAGIT® E 100 (granules) is an immediate-release polymer used as a taste masking, coating agent & film former in tablets, capsules, powders & ODTs.
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Amino Methacrylate Copolymer
Category : Controlled & Modified Release
Brand : EUDRAGIT® E 100
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.
Dosage Form : Gel
Grade : Oral
Application : Controlled & Modified Release
Excipient Details : OraRez AN is a copolymer of methyl vinyl ether & maleic anhydride, used in topical products such as hydrogel and in controlled release of bioactives.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Methyl Vinyl Ether and Maleic Anhydride Copolymer
Dosage Form : Gel
Grade : Oral
Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.
Ingredient(s) : Methyl Vinyl Ether and Maleic Anhydride Copolymer
Dosage Form : Gel
Category : Controlled & Modified Release
Brand : ORAREZ AN
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Gangwal Healthcare is powered by innovation, driving health, wellness & healing.
Application : Controlled & Modified Release
Excipient Details : Complexol-HP (Hydroxypropyl Betacyclodextrin) is used as stabilizer, solubilizer & taste masking agent in solids, liquids, ophthalmics & injectables.
Pharmacopoeia Ref : BP/EP/USP-NF
Technical Specs : NA
Ingredient(s) : Hydroxypropyl Betacyclodextrin
Gangwal Healthcare is powered by innovation, driving health, wellness & healing.
Ingredient(s) : Hydroxypropyl Betacyclodextrin
Dosage Form : Capsule, Emulsion, Solution, Tablet
Category : Controlled & Modified Release
Brand : COMPLEXOL HP®
Pharmacopoeia Ref : BP/EP/USP-NF
Technical Specs : NA
Grade : Oral, Parenteral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Application : Controlled & Modified Release
Excipient Details : EUDRAGIT® L 100 (powder), a delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : METHACRYLIC ACID COPOLYMER TYPE A
Category : Controlled & Modified Release
Brand : EUDRAGIT® L 100
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Brand Name : EUDRAGIT® L 100-55
Application : Controlled & Modified Release
Excipient Details : EUDRAGIT® L 100-55 (powder) is used in delayed release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules & granules.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer
Category : Controlled & Modified Release
Brand : EUDRAGIT® L 100-55
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Gangwal Healthcare is powered by innovation, driving health, wellness & healing.
Application : Controlled & Modified Release
Excipient Details : DiCOM-DC SR300 is used as a directly compressible, rate-controlling, and co-processed excipient in sustained-release tablets and capsules.
Pharmacopoeia Ref : In-house
Technical Specs : NA
Ingredient(s) : EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc
Gangwal Healthcare is powered by innovation, driving health, wellness & healing.
Brand : DICOM-DC® SR300
Pharmacopoeia Ref : In-house
Technical Specs : NA
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Application : Controlled & Modified Release
Excipient Details : EUDRAGIT® RL 100 (granules) is an excipient used as a solubilizer in combination with Eudragit® RS for creating sustained release drugs.
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Ammonia Methacrylate Copolymer Type A
Category : Controlled & Modified Release
Brand : EUDRAGIT® RL 100
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Application : Controlled & Modified Release
Excipient Details : EUDRAGIT® RS, a functional sustained release polymer, used in combination with EUDRAGIT® RL for customized release profiles in tablets, capsules, etc.
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Ammonio Methacrylate Copolymer Type B
Category : Controlled & Modified Release
Brand : EUDRAGIT® RS 100
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Application : Controlled & Modified Release
Excipient Details : EUDRAGIT® S 100, a delayed release polymer can be combined with other polymers for precise targeting and rapid drug release in tablets, capsules, etc.
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Methacrylic Acid Copolymer Type B
Category : Controlled & Modified Release
Brand : EUDRAGIT® S 100
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Application : Controlled & Modified Release
Excipient Details : PlasACRYL HTP20 is an easy-to-use glidant & plasticizer premix, specifically designed for EUDRAGIT® L 30 D-55 products such as capsules, tablets, etc.
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : PLASACRYL HTP20
Category : Controlled & Modified Release
Brand : PLASACRYL® HTP20
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Application : Controlled & Modified Release
Excipient Details : PlasACRYL® T20 is an easy-to-use glidant & plasticizer premix, specifically designed for EUDRAGIT® FS 30 D products such as capsules, tablets, etc.
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : PLASACRYL T20
Category : Controlled & Modified Release
Brand : PLASACRYL® T20
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Gangwal Healthcare is powered by innovation, driving health, wellness & healing.
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Application : Controlled & Modified Release
Excipient Details : Gellets-P are Microcrystalline Cellulose based spheres for the manufacturing of pellets and modified release products.
Pharmacopoeia Ref : In-house
Technical Specs : NA
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Gangwal Healthcare is powered by innovation, driving health, wellness & healing.
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Capsule, Granule / Pellet, Tablet
Category : Controlled & Modified Release
Brand : GELLETS-P®
Applications : Gellets-P are Microcrystalline Cellulose based spheres for the manufacturing of pellets and modified release products.
Pharmacopoeia Ref : In-house
Technical Specs : NA
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Dosage Form : Granule / Pellet, Tablet
Grade : Oral
Brand Name : EUDRAGIT® RL 30 D
Application : Controlled & Modified Release
Excipient Details : Eudragit RL 30 D(aqueous dispersion) is a sustained release polymer for customized release profiles, used in combination with EUDRAGIT® RS.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer
Dosage Form : Granule / Pellet, Tablet
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer
Dosage Form : Granule / Pellet, Tablet
Category : Controlled & Modified Release
Brand : EUDRAGIT® RL 30 D
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Dosage Form : Tablet
Grade : Oral
Application : Controlled & Modified Release
Excipient Details : EUDRAGIT® RS PO (Powder) is an insoluble sustained release polymer for customized release profiles used in combination with EUDRAGIT® RL.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Ammonio Methacrylate Copolymer Excipient
Dosage Form : Tablet
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Ammonio Methacrylate Copolymer Excipient
Dosage Form : Tablet
Category : Controlled & Modified Release
Brand : EUDRAGIT® RS PO
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Dosage Form : Tablet
Grade : Oral
Brand Name : EUDRAGIT® RS 30 D
Application : Controlled & Modified Release
Excipient Details : EUDRAGIT® RS 30 D(aqueous dispersion) is a sustained release polymer for customized release profiles used in combination with EUDRAGIT® RL.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer
Dosage Form : Tablet
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer
Dosage Form : Tablet
Category : Controlled & Modified Release
Brand : EUDRAGIT® RS 30 D
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Dosage Form : Tablet
Grade : Oral
Brand Name : EUDRAGIT® RS 12,5
Application : Controlled & Modified Release
Excipient Details : EUDRAGIT® RS 12,5 (Organic solution) is a sustained release polymer for customized release profiles used in combination with EUDRAGIT® RL.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer, Methacrylic Acid Excipient
Dosage Form : Tablet
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer, Methacrylic Acid Excipient
Dosage Form : Tablet
Category : Controlled & Modified Release
Brand : EUDRAGIT® RS 12,5
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Dosage Form : Granule / Pellet, Tablet
Grade : Oral
Brand Name : EUDRAGIT® NE 30 D
Application : Controlled & Modified Release
Excipient Details : Eudragit NE 30 D (aqueous dispersion) is a highly flexible sustained release polymer used for coating (without plasticizer) in OSDs.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer
Dosage Form : Granule / Pellet, Tablet
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer
Dosage Form : Granule / Pellet, Tablet
Category : Controlled & Modified Release
Brand : EUDRAGIT® NE 30 D
Applications : Eudragit NE 30 D (aqueous dispersion) is a highly flexible sustained release polymer used for coating (without plasticizer) in OSDs.
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Dosage Form : Granule / Pellet, Tablet
Grade : Oral
Brand Name : EUDRAGIT® NE 40 D
Application : Controlled & Modified Release
Excipient Details : EUDRAGIT® NE 40 D (aqueous dispersion) is a sustained release polymer used for coating tablets, granules and pellets.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer
Dosage Form : Granule / Pellet, Tablet
Grade : Oral
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer
Dosage Form : Granule / Pellet, Tablet
Category : Controlled & Modified Release
Brand : EUDRAGIT® NE 40 D
Applications : EUDRAGIT® NE 40 D (aqueous dispersion) is a sustained release polymer used for coating tablets, granules and pellets.
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Oral
LOOKING FOR A SUPPLIER?
